Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-Dose Chemotherapy

This study has been completed.
Information provided by Amgen

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Stomatitis
2		Additional conditions recognized in this trial
			Hematologic Neoplasms
3		More general conditions related to this trial
			Hematologic Diseases
			Mouth Diseases
			Neoplasms
			Neoplasms by Site
			Stomatognathic Diseases
4		Sponsors listed in this trial
			Amgen